Differentially expressed genes in CD34+ cells in Ph-negative myeloproliferative neoplasms: bioinformatics meta-analysis of three independent studies
- Authors: Timechko E.E.1, Yakimov A.M.1, Tyumentseva A.V.2, Stolyar M.A.2, Gorbenko A.S.2, Olkhovskiy I.A.2,3
-
Affiliations:
- Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
- Federal Research Center “Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences”
- Krasnoyarsk Branch of the National Medical Research Center for Hematology, Ministry of Health of Russia
- Issue: Vol 21, No 3 (2026)
- Pages: 113-126
- Section: CURRENT BASIC RESEARCH IN HEMATOLOGY AND PRACTICAL MEDICINE
- Published: 30.09.2026
- URL: https://oncohematology.abvpress.ru/ongm/article/view/1075
- DOI: https://doi.org/10.17650/1818-8346-2026-21-3-113-126
- ID: 1075
Cite item
Abstract
Accumulating evidence suggests that the molecular pathobiology of Ph-negative myeloproliferative neoplasms (MPNs) is significantly more complex than expected, with associated somatic mutations failing to fully explain the underlying causes and maintaining a high degree of uncertainty regarding individual disease prognosis. Given the involvement of epigenetic mechanisms of carcinogenesis in altered gene expression, attempts have been made to identify specific transcriptome alterations in hematopoietic cells in MPNs. However, these results often inconsistently reflect the use of different analytical technologies, statistical approaches, and the small number of patients included.
Aim – to perform a bioinformatics meta-analysis of available databases of primary results from microarray studies of CD34+ cell RNA profiling in patients with MPNs.
The NCBI GEO catalog was used to search for raw data. After searching for the keyword “myeloproliferative neoplasm”, three independent databases were identified that matched the Affymetrix analytical platform and biomaterial type. Processing was performed in the integrated RStudio development environment using the oligo package. Gene expression normalization was performed using the robust multiarray average method. Differential gene expression analysis in CD34+ cells between patient groups was performed using the limma package. To enhance the reliability of the results, a meta-analysis was performed using a combination of Fisher’s and Stauffer’s methods, with the Jackknife procedure used for final filtering.
The meta-analysis identified 33 genes common to MPN, as well as 7, 204, and 1806 genes specific to essential thrombocythemia, polycythemia vera, and primary myelofibrosis, respectively, that were differentially expressed. The PIM1 gene expression level significantly varied in the series control → essential thrombocythemia → polycythemia vera → primary myelofibrosis. The functional annotation confirms the pathogenetic mechanisms of the disease: impaired DNA repair, apoptosis, proliferative and functional activation, and the development of inflammatory processes in the bone marrow. It also demonstrates the multilevel nature of the interactions between intracellular signaling pathways and the pleiotropy of regulatory processes in carcinogenesis. Overall, the obtained data are consistent with Dameshek’s biological continuum postulate, which suggests a single pathogenetic mechanism for the evolution of MPNs.
About the authors
E. E. Timechko
Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: krashemcenter@mail.ru
ORCID iD: 0000-0002-4555-7457
Russian Federation, 1 Partizana Zheleznyaka St., Krasnoyarsk 660022
A. M. Yakimov
Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: krashemcenter@mail.ru
ORCID iD: 0009-0006-0479-126X
Russian Federation, 1 Partizana Zheleznyaka St., Krasnoyarsk 660022
A. V. Tyumentseva
Federal Research Center “Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences”
Email: krashemcenter@mail.ru
ORCID iD: 0000-0002-2269-0298
Russian Federation, 50 Akademgorodok St., Krasnoyarsk 660036
M. A. Stolyar
Federal Research Center “Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences”
Email: krashemcenter@mail.ru
ORCID iD: 0000-0002-8037-9844
Russian Federation, 50 Akademgorodok St., Krasnoyarsk 660036
A. S. Gorbenko
Federal Research Center “Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences”
Email: krashemcenter@mail.ru
ORCID iD: 0000-0001-8756-2660
Russian Federation, 50 Akademgorodok St., Krasnoyarsk 660036
I. A. Olkhovskiy
Federal Research Center “Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences”; Krasnoyarsk Branch of the National Medical Research Center for Hematology, Ministry of Health of Russia
Author for correspondence.
Email: krashemcenter@mail.ru
ORCID iD: 0000-0003-2311-2219
Russian Federation, 50 Akademgorodok St., Krasnoyarsk 660036; Build. 45, 50 Akademgorodok St., Krasnoyarsk 660036
References
- Меликян А.Л., Суборцева И.Н., Ковригина А.М., и др. Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.). Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2024;17(3):291–334. doi: 10.21320/2500-2139-2024-17-3-291-334.
- Melikyan A.L., Subortseva I.N., Kovrigina A.M., et al. National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024). Clinical Oncohematology. Basic Research and Clinical Practice. 2024;17(3):291–334. doi: 10.21320/2500-2139-2024-17-3-291-334. (in Russian)
- Melo-Cardenas J., Migliaccio A.R., Crispino J.D. The Role of Megakaryocytes in Myelofibrosis. Hematol Oncol Clin North Am. 2021;35(2):191-203. PMID: 33641863. doi: 10.1016/j.hoc.2020.11.004
- Dameshek W. Some speculations on the myeloproliferative syndromes [editorial]. Blood. 1951;6(4):372-375. PMID: 26869302. doi: 10.1182/blood-2015-12-686402.
- Grinfeld J., Nangalia J., Green A.R. Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms. Haematologica. 2017;102(1):7-17. PMID: 27909216, doi: 10.3324/haematol.2014.113845
- Skov V., Thomassen M., Riley C.H., et al. Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis. Exp Hematol. 2012;40(9):771-780.e19. PMID: 22659388. doi: 10.1016/j.exphem.2012.05.011.
- Wong W.J., Baltay M., Getz A., et al. Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures. PLoS One. 2019;14(5):e0216810. PMID: 31071164. doi: 10.1371/journal.pone.0216810.
- Pardanani A., Lasho T.L., Finke C., et al. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia. 2007 Sep;21(9):1960-3. PMID: 17597810. doi: 10.1038/sj.leu.2404810.
- Luque Paz D., Kralovics R., Skoda R.C. Genetic basis and molecular profiling in myeloproliferative neoplasms. Blood. 2023;141(16):1909-1921. PMID: 36347013. doi: 10.1182/blood.2022017578.
- Меликян А.Л., Суборцева И.Н. Биология миелопролиферативных новообразований. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2016;9(3):314–325. doi: 10.21320/2500-2139-2016-9-3-314-325.
- Melikyan A.L., Subortseva I.N. Biology of Myeloproliferative Malignancies. Clinical Oncohematology. Basic Research and Clinical Practice. 2016;9(3):314–325. doi: 10.21320/2500-2139-2016-9-3-314-325. (in Russian)
- Čokić V.P., Mossuz P., Han J., et al. Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway. PLoS One. 2015;10(8):e0135463. PMID: 26275051. doi: 10.1371/journal.pone.0135463.
- Baumeister J., Maié T., Chatain N., et al. Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells. Ann Hematol. 2021;100(12):2943-2956. PMID: 34390367. doi: 10.1007/s00277-021-04615-8.
- Tenedini E., Fagioli M.E., Vianelli N., et al. Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells. Blood. 2004;104(10):3126-35. PMID: 15271793. doi: 10.1182/blood-2003-07-2597.
- Walter W., Nadarajah N., Hutter S., et al. Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase. Leukemia. 2024;38(12):2644-2652. PMID: 39341969. doi: 10.1038/s41375-024-02425-1.
- Li S., Wu S., Xu M., et al. Potential application of the bulk RNA sequencing in routine MPN clinics. BMC Cancer. 2025;25(1):746. PMID: 40264064. doi: 10.1186/s12885-025-13947-x.
- Barrett T., Wilhite S.E., Ledoux P., et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41(Database issue):D991-5. PMID: 23193258. doi: 10.1093/nar/gks1193.
- Carvalho B.S., Irizarry R.A. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26(19):2363-7. PMID: 20688976. doi: 10.1093/bioinformatics/btq431.
- Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2):185-93. PMID: 12538238. doi: 10.1093/bioinformatics/19.2.185.
- Ritchie M.E., Phipson B., Wu D., et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. PMID: 25605792. doi: 10.1093/nar/gkv007.
- Kotz S., Johnson N.L. (eds) Breakthroughs in Statistics. Springer Series in Statistics. New York: Springer, 1992, 628 pp.
- Stouffer S.A., Lumsdaine A.A., Lumsdaine M.H., et al. The American soldier: Combat and its aftermath. (Studies in social psychology in World War II). Princeton University Press., 1949.
- Пакет «statannotations». Доступно по: https://statannotations.readthedocs.io/en/latest/statannotations.html
- ShinyGO 0.85.1. Доступно по: https://bioinformatics.sdstate.edu/go/
- StringDB. Доступно по: https://string-db.org
- Wickham H. ggplot2. Elegant Graphics for Data Analysis. New York: Springer, 2009.
- Wu S., Li Z., Gnatenko D.V., et al. BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans. Blood. 2016;128(5):699-709. PMID: 27207795. doi: 10.1182/blood-2016-02-696997.
- Nesbitt N.M., Araldi G.L., Pennacchia L., et al. Small molecule BLVRB redox inhibitor promotes megakaryocytopoiesis and stress thrombopoiesis in vivo. Nat Commun. 2025;16(1):3480. PMID: 40216753. doi: 10.1038/s41467-025-58497-9.
- Xie S., Wu F., Zhao X. et al. MED16 Negatively Regulates Erythropoiesis and Myelopoiesis through Modulation of Chromatin Accessibility. 65th ASH Annual Meeting Abstracts. 2023;142(Supp. 1): 2673.
- Mukherjee K., Bieker J.J. Transcriptional Control of Gene Expression and the Heterogeneous Cellular Identity of Erythroblastic Island Macrophages. Front Genet. 2021;12:756028. PMID: 34880902. doi: 10.3389/fgene.2021.756028.
- Fan W., Cao W., Shi J., et al. Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation. Ann Hematol. 2023;102(7):1745-1759. PMID: 37233774. doi: 10.1007/s00277-023-05284-5.
- HSPBP1 Phenotypes with the most-significant associations for this locus. Доступно по: https://koges.leelabsg.org/region/KoGES_PLT/gene/HSPBP1
- Spi vak J.L., Jie C., Williams D., Moliterno A.R. JAK2V671F, Gender and the Gene Expression Profile of Polycythemia Vera. Blood. 2008;112(11):2805–2805. doi: 10.1182/blood.V112.11.2805.2805.
- Noetzli L., Parvin S., Battinelli E., Machlus K. CCL5 Enhances Megakaryocyte Differentiation and Development. Blood [Internet]. 2018;132(Supplement 1):522–522.
- Yoshioka S., Okimura Y., Takahashi Y., et al. Up-regulation of mitochondrial transcription factor 1 mRNA levels by GH in VSMC. Life Sci. 2004;74(17):2097-109. PMID: 14969715, doi: 10.1016/j.lfs.2003.07.057.
- Caiado F., Pietras E.M., Manz M.G. Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med. 2021;218(7):e20201541. PMID: 34129016. doi: 10.1084/jem.20201541
- Rice K.L., Lin X., Wolniak K., et al. Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms. Blood Cancer J. 2011;1(11):e40. PMID: 22829077. doi: 10.1038/bcj.2011.39.
- Nakazawa H., Kaiume H., Igarashi K., et al. A Diagnostic Impact of Serum Autotaxin Levels in Patients with Bone Marrow Fibrosis. Clin Lymphoma Myeloma Leuk. 2023;23(2):e117-e124. PMID: 36567212. doi: 10.1016/j.clml.2022.12.006.
- Patent US10632104B2 Autotaxin inhibitors and uses thereof. BainJillian G., EvansJohn F., Hutchinson H., Lonergan D. Опубл. 08.12.2011.
- Lally J., Boasman K., Brown L., et al. GATA-1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis. J Thromb Haemost. 2019;17(6):896-900. PMID: 30889303. doi: 10.1111/jth.14433.
- Kelliher S., Gamba S., Weiss L., et al. Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms. Blood Adv. 2024;8(16):4276-4280. PMID: 38861353. doi: 10.1182/bloodadvances.2023012016.
- Falanga A., Marchetti M., Russo L. Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand? Semin Thromb Hemost. 2021;47(8):962-971. PMID: 34450680. doi: 10.1055/s-0041-1733925.
- Barneda-Zahonero B., Román-González L., Collazo O., et al. HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages. PLoS Genet. 2013;9(5):e1003503. PMID: 23696748. doi: 10.1371/journal.pgen.1003503.
- Wang P., Wang Z., Liu J. Role of HDACs in normal and malignant hematopoiesis. Mol Cancer. 2020;19(1):5. PMID: 31910827. doi: 10.1186/s12943-019-1127-7.
- Visconte V., Rogers H.J., Singh J, et al. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood. 2012;120(16):3173-86. PMID: 22826563. doi: 10.1182/blood-2012-05-430876.
- Joehanes R., Johnson A.D., Barb J.J., et al. Gene expression analysis of whole blood, peripheral blood mononuclear cells, and lymphoblastoid cell lines from the Framingham Heart Study. Physiol Genomics. 2012;44(1):59-75. PMID: 22045913. doi: 10.1152/physiolgenomics.00130.2011.
- Dunbar A.J., Kim D., Lu M., et al. CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis. Blood. 2023;141(20):2508-2519. PMID: 36800567. doi: 10.1182/blood.2022015418.
- Skov V., Thomassen M., Kjaer L., et al. Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms. Eur J Haematol. 2023;111(5):805-814. PMID: 37640394. doi: 10.1111/ejh.14081.
- Lee S.H., Lin C.C., Wei C.H., et al. PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients. J Pathol Clin Res. 2022;8(1):78-87. PMID: 34480529. doi: 10.1002/cjp2.240.
- Wang J.C., Sun L. PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph(-) Myeloproliferative Neoplasm: A Review. Int J Mol Sci. 2022;23(10):5837. PMID: 35628647. doi: 10.3390/ijms23105837.
- Tefferi A., Vaidya R., Caramazza D., et al. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. J Clin Oncol. 2011;29(10):1356-63. PMID: 21300928. doi: 10.1200/JCO.2010.32.9490.
- Nock S., Karim E., Unsworth A.J. Pim Kinases: Important Regulators of Cardiovascular Disease. Int J Mol Sci. 2023;24(14):11582. PMID: 37511341. doi: 10.3390/ijms241411582.
- Huang S.M., Wang A., Greco R., et al. Combination of PIM and JAK2 inhibitors synergistically suppresses MPN cell proliferation and overcomes drug resistance. Oncotarget. 2014;5(10):3362-74. PMID: 24830942. doi: 10.18632/oncotarget.1951.
- Bellon M., Nicot C. Targeting Pim kinases in hematological cancers: molecular and clinical review. Mol Cancer. 2023;22(1):18. PMID: 36694243. doi: 10.1186/s12943-023-01721-1.
Supplementary files

